Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease

被引：0
|
作者：
Zamora-Legoff, Alex [1 ]
Krause, Megan [2 ]
Crowson, Cynthia S. [3 ]
Ryu, Jay H. [4 ]
Matteson, Eric L. [2 ]
机构：
[1] Mayo Clin, Div Rheumatol, Rochester, MN USA
[2] Mayo Clin, Rheumatol, Rochester, MN USA
[3] Mayo Clin, Hlth Sci Res, Rochester, MN USA
[4] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1496
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease
    Bes, Cemal
    Koybasi, Gizem
    Icacan, Ozan Cemal
    Mutlu, Melek Yalcin
    Yildirim, Fatih
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (03) : 176 - 179
  • [42] Biomarkers of Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Chen, Juan
    Doyle, Tracy J.
    Liu, Yongliang
    Aggarwal, Rohit
    Wang, Xiaoping
    Shi, Yonghong
    Ge, Sheng Xiang
    Huang, Heqing
    Lin, Qingyan
    Liu, Wen
    Cai, Yongjin
    Koontz, Diane
    Fuhrman, Carl R.
    Golzarri, Maria F.
    Liu, Yushi
    Hatabu, Hiroto
    Nishino, Mizuki
    Araki, Tetsuro
    Dellaripa, Paul F.
    Oddis, Chester V.
    Rosas, Ivan O.
    Ascherman, Dana P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (01) : 28 - 38
  • [43] Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
    Mohning, Michael P.
    Amigues, Isabelle
    Demoruelle, M. Kristen
    Perez, Evans R. Fernandez
    Huie, Tristan J.
    Keith, Rebecca K.
    Olson, Amy L.
    Yunt, Zulma X.
    Chung, Jonathan H.
    Hobbs, Stephen
    Swigris, Jeffrey J.
    Solomon, Joshua J.
    [J]. ERJ OPEN RESEARCH, 2021, 7 (01)
  • [44] Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
    Wolfe, F.
    Caplan, L.
    Michaud, K.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (03) : 172 - 178
  • [45] Nintedanib in rheumatoid arthritis associated-interstitial lung disease
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (08): : E551 - E551
  • [46] Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
    Suissa, Samy
    Hudson, Marie
    Ernst, Pierre
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1435 - 1439
  • [47] Duration Of Rheumatoid Arthritis And The Risk Of Developing Interstitial Lung Disease
    Mohning, M.
    Yunt, Z.
    Keith, R. C.
    Olson, A.
    Perez, E. Fernandez
    Huie, T.
    Demoruelle, M.
    Goldstein, B.
    Swigris, J. J.
    Solomon, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
    Kim, E. J.
    Elicker, B. M.
    Maldonado, F.
    Webb, W. R.
    Ryu, J. H.
    Van Uden, J. H.
    Lee, J. S.
    King, T. E., Jr.
    Collard, H. R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (06) : 1322 - 1328
  • [49] Mast cells in rheumatoid arthritis associated interstitial lung disease and idiopathic interstitial lung disease.
    Atkins, SR
    Matteson, EL
    Ryu, JH
    Myers, JL
    Bongartz, T
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S582 - S582
  • [50] Interstitial lung disease in rheumatoid arthritis
    Ascherman D.P.
    [J]. Current Rheumatology Reports, 2010, 12 (5) : 363 - 369
12345